Angiotensin-converting enzyme inhibitors and cytokines in heart failure: dose and effect?
- 31 December 1999
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (7) , 2068-2071
- https://doi.org/10.1016/s0735-1097(99)00476-3
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- An overview of tumor necrosis factor α and the failing human heartCurrent Opinion in Cardiology, 1999
- Reverse remodeling in heart failure with intensification of vasodilator therapyClinical Cardiology, 1997
- The Tumor Necrosis Factor Ligand and Receptor FamiliesNew England Journal of Medicine, 1996
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Serum Tumor Necrosis Factor Levels in Acute Myocardial Infarction and Unstable Angina PectorisAngiology, 1993
- Circulating tumour necrosis factor‐α (cachectin) in myocardial infarctionJournal of Internal Medicine, 1989
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977